Total Return chart Basilea Pharmaceutica AG

Stocks

Real-time Estimate Cboe Europe Other stock markets 07:30:44 2026-07-24 EDT			5-day change	1st Jan Change
52.15 ^CHF	-0.29%		+0.77%	-4.57%

05-28	Basilea Pharmaceutica Ltd Receives Additional USD 13.3 Million From BARDA To Continue Development Of Novel Antibiotic Ceftibuten-Ledaborbactam Etzadroxil	CI
05-28	Basilea Pharmaceutica Gets Additional $13 Million Funding for Antibiotic Development	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.

2013-04-10

Annual 5 CHF